DRUGS MADE IN AMERICA ACQUIS (DMAA) Stock Price & Overview
NASDAQ:DMAA • KYG2847J1040
Current stock price
The current stock price of DMAA is 10.51 USD. Today DMAA is down by 0%. In the past month the price increased by 0.38%. In the past year, price increased by 4.79%.
DMAA Key Statistics
- Market Cap
- 352.295M
- P/E
- 52.55
- Fwd P/E
- N/A
- EPS (TTM)
- 0.20
- Dividend Yield
- N/A
DMAA Stock Performance
DMAA Stock Chart
DMAA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to DMAA. When comparing the yearly performance of all stocks, DMAA turns out to be only a medium performer in the overall market: it outperformed 46.91% of all stocks.
DMAA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to DMAA. The financial health of DMAA is average, but there are quite some concerns on its profitability.
DMAA Earnings
DMAA Forecast & Estimates
DMAA Financial Highlights
Over the last trailing twelve months DMAA reported a non-GAAP Earnings per Share(EPS) of 0.2.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | 2.29% | ||
| ROE | 2.37% | ||
| Debt/Equity | 0 |
DMAA Ownership
About DMAA
Company Profile
Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-01-28. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenues.
Company Info
IPO: 2025-01-28
DRUGS MADE IN AMERICA ACQUIS
1 East Broward Boulevard, Suite 700
Fort Lauderdale FLORIDA US
Employees: 0
Phone: 19548703099
DRUGS MADE IN AMERICA ACQUIS / DMAA FAQ
What does DMAA do?
Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-01-28. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The firm intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenues.
Can you provide the latest stock price for DRUGS MADE IN AMERICA ACQUIS?
The current stock price of DMAA is 10.51 USD.
What is the dividend status of DRUGS MADE IN AMERICA ACQUIS?
DMAA does not pay a dividend.
What is the ChartMill technical and fundamental rating of DMAA stock?
DMAA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the short interest for DMAA stock?
The outstanding short interest for DRUGS MADE IN AMERICA ACQUIS (DMAA) is 0.1% of its float.